ARCHIVES

Congress Insists On No Downward Negotiations; NCI May Drop 2000 To 300 Grants In FY 1991

This article is from The Cancer Letter archive.

Vol. 16 No. 43 | November 9, 1990

Download PDF Visit The Full Archive

Related Articles

Cell Behavior Changes Noted At Baltimore Symposium

January 8, 1982

Firm Buys Rights To NKT Cells From Beth Israel Deaconess.

July 28, 2000

Nevins Reverses Position, Claims Potti Manipulated Data For Basis of Clinical Trials

February 17, 2012

Amgen Pays $24.9 Million To Settle Kickback Charges

April 19, 2013

Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products.

April 22, 2005

CGAP Speeding Gene Discovery

April 30, 1999